These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26302380)

  • 1. Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models.
    Liu F; Porco TC; Amza A; Kadri B; Nassirou B; West SK; Bailey RL; Keenan JD; Solomon AW; Emerson PM; Gambhir M; Lietman TM
    PLoS Negl Trop Dis; 2015 Aug; 9(8):e0004000. PubMed ID: 26302380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection.
    Liu F; Porco TC; Amza A; Kadri B; Nassirou B; West SK; Bailey RL; Keenan JD; Lietman TM
    Parasit Vectors; 2015 Oct; 8():535. PubMed ID: 26489933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger.
    Kim JS; Oldenburg CE; Cooley G; Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Keenan JD; Gaynor BD; Porco TC; Lietman TM; Martin DL
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007127. PubMed ID: 30689671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial.
    Arzika AM; Mindo-Panusis D; Abdou A; Kadri B; Nassirou B; Maliki R; Alsoudi AF; Zhang T; Cotter SY; Lebas E; O'Brien KS; Callahan EK; Bailey RL; West SK; Goodhew EB; Martin DL; Arnold BF; Porco TC; Lietman TM; Keenan JD;
    JAMA Netw Open; 2022 Aug; 5(8):e2228244. PubMed ID: 35997979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community risk factors for ocular Chlamydia infection in Niger: pre-treatment results from a cluster-randomized trachoma trial.
    Amza A; Kadri B; Nassirou B; Stoller NE; Yu SN; Zhou Z; Chin S; West SK; Bailey RL; Mabey DC; Keenan JD; Porco TC; Lietman TM; Gaynor BD;
    PLoS Negl Trop Dis; 2012; 6(4):e1586. PubMed ID: 22545165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
    Keenan JD; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Emerson PM; Callahan K; Cotter SY; Stoller NE; Porco TC; Oldenburg CE; Lietman TM
    PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Cluster-Randomized Trial to Assess the Efficacy of Targeting Trachoma Treatment to Children.
    Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; Zhou Z; Bailey RL; Mabey DC; Porco TC; Keenan JD; Gaynor BD; West SK; Lietman TM
    Clin Infect Dis; 2017 Mar; 64(6):743-750. PubMed ID: 27956455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of expanding annual mass azithromycin distribution treatment coverage for trachoma in Niger: a cluster randomised trial.
    Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Gaynor BD; Keenan JD; Lietman TM; Oldenburg CE
    Br J Ophthalmol; 2018 May; 102(5):680-686. PubMed ID: 28893761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of oral azithromycin in clearing ocular chlamydia: mathematical modeling from a community-randomized trachoma trial.
    Liu F; Porco TC; Mkocha HA; Muñoz B; Ray KJ; Bailey RL; Lietman TM; West SK
    Epidemics; 2014 Mar; 6():10-7. PubMed ID: 24593917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma.
    Melese M; Alemayehu W; Lakew T; Yi E; House J; Chidambaram JD; Zhou Z; Cevallos V; Ray K; Hong KC; Porco TC; Phan I; Zaidi A; Gaynor BD; Whitcher JP; Lietman TM
    JAMA; 2008 Feb; 299(7):778-84. PubMed ID: 18285589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Childhood Mortality After Mass Distribution of Azithromycin: A Secondary Analysis of the PRET Cluster-randomized Trial in Niger.
    O'Brien KS; Cotter SY; Amza A; Kadri B; Nassirou B; Stoller NE; Zhou Z; West SK; Bailey RL; Keenan JD; Porco TC; Lietman TM
    Pediatr Infect Dis J; 2018 Nov; 37(11):1082-1086. PubMed ID: 29561511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The easiest children to reach are most likely to be infected with ocular Chlamydia trachomatis in trachoma endemic areas of Niger.
    Amza A; Kadri B; Nassirou B; Yu SN; Stoller NE; Bhosai SJ; Zhou Z; McCulloch CE; West SK; Bailey RL; Keenan JD; Lietman TM; Gaynor BD
    PLoS Negl Trop Dis; 2013; 7(1):e1983. PubMed ID: 23326612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probabilistic forecasts of trachoma transmission at the district level: A statistical model comparison.
    Pinsent A; Liu F; Deiner M; Emerson P; Bhaktiari A; Porco TC; Lietman T; Gambhir M
    Epidemics; 2017 Mar; 18():48-55. PubMed ID: 28279456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trachoma surveillance in Australia, 2009. A report by the National Trachoma Surveillance and Reporting Unit.
    Adams KS; Burgess JA; Dharmage SC; Taylor H;
    Commun Dis Intell Q Rep; 2010 Dec; 34(4):375-95. PubMed ID: 21413525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics for trachoma.
    Evans JR; Solomon AW
    Cochrane Database Syst Rev; 2011 Mar; (3):CD001860. PubMed ID: 21412875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study.
    Burton MJ; Holland MJ; Makalo P; Aryee EA; Alexander ND; Sillah A; Faal H; West SK; Foster A; Johnson GJ; Mabey DC; Bailey RL
    Lancet; 2005 Apr 9-15; 365(9467):1321-8. PubMed ID: 15823382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial.
    Gebre T; Ayele B; Zerihun M; Genet A; Stoller NE; Zhou Z; House JI; Yu SN; Ray KJ; Emerson PM; Keenan JD; Porco TC; Lietman TM; Gaynor BD
    Lancet; 2012 Jan; 379(9811):143-51. PubMed ID: 22192488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Antibiotic Selection Pressure on the Nasopharyngeal Macrolide Resistome: A Cluster-randomized Trial.
    Keenan JD; Chin SA; Amza A; Kadri B; Nassirou B; Cevallos V; Cotter SY; Zhou Z; West SK; Bailey RL; Porco TC; Lietman TM;
    Clin Infect Dis; 2018 Nov; 67(11):1736-1742. PubMed ID: 29897440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass treatment with single-dose azithromycin for trachoma.
    Solomon AW; Holland MJ; Alexander ND; Massae PA; Aguirre A; Natividad-Sancho A; Molina S; Safari S; Shao JF; Courtright P; Peeling RW; West SK; Bailey RL; Foster A; Mabey DC
    N Engl J Med; 2004 Nov; 351(19):1962-71. PubMed ID: 15525721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania.
    West SK; Munoz B; Mkocha H; Gaydos CA; Quinn TC
    J Infect Dis; 2011 Jul; 204(2):268-73. PubMed ID: 21673038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.